Vytrus Biotech S.A. (VYT) — Cash Flow-to-Debt Ratio
Vytrus Biotech S.A. (VYT) has a Cash Flow-to-Debt Ratio of 0.07x as of December 2022, meaning its operating cash flow of €225.55K could theoretically repay 0% of its total liabilities (€3.25 Million) in one year. See VYT FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vytrus Biotech S.A. Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Vytrus Biotech S.A. across 6 annual periods. For the full cash flow conversion analysis, see Vytrus Biotech S.A. cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Vytrus Biotech S.A. (2020–2025)
Year-by-year debt coverage analysis for Vytrus Biotech S.A.. Check Vytrus Biotech S.A. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.90x | €3.90 Million | €4.35 Million | ▲ +86.5% |
| 2024 | 0.48x | €1.84 Million | €3.84 Million | ▲ +113.6% |
| 2023 | 0.22x | €904.39K | €4.02 Million | ▲ +224.0% |
| 2022 | 0.07x | €225.55K | €3.25 Million | ▼ -54.6% |
| 2021 | 0.15x | €447.92K | €2.93 Million | ▲ +399.7% |
| 2020 | -0.05x | €-132.47K | €2.60 Million | — |